Organoids Market – Pharmaceutical Companies Lead Adoption of...

σε πρόσθεσε στο Wellness

2026-08-21 09:20:04 - Μετάφραση -

Organoids Market – Pharmaceutical Companies Lead Adoption of 3D Biology

Pharmaceutical companies are the largest end users in the organoids market. They use organoid models to improve drug discovery, toxicity testing, disease research, and treatment-response analysis. The market was valued at approximately USD 1.68 billion in 2024 and is expected to reach about USD 17.21 billion by 2035, expanding at a CAGR of approximately 23.55%. Pharmaceutical companies account...

0 Σχόλια 0 Μοιράστηκε 6 Views 0 Προεπισκόπηση